logo

For the Inventor, By the Inventor

Solana Beach, CA, United States of America

Carlos F Barbas, Iii

This inventor holds 51 USPTO granted patents and 9 published patent applications and 3 EPO patents, primarily in Antibody Engineering (CPC class C07K). Top assignees: Scripps Research Institute, Syngenta Participations Ag, Novartis Ag. Active years: 1997-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlos F Barbas, Iii. Retrieved from https://idiyas.com/inventor/carlos-f-barbas-iii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 51 

% Patents Active = 64.7

 

Average Co-Inventor Count = 2.2

ph-index = 18

Forward Citations = 1,801(Granted Patents)

Forward Citations (Not Self Cited) = 1,778(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • San Diego, CA (US) (1997 - 2008)
  • Del Mar, CA (US) (2008)
  • Solana Beach, CA (US) (2002 - 2017)
  • La Jolla, CA (US) (2010 - 2022)

Company Filing History:

goldMedal49 out of 1,208 
 
Scripps Research Institute
 patents
silverMedal3 out of 1,779 
 
Syngenta Participations Ag
 patents
bronzeMedal2 out of 3,978 
 
Novartis Ag
 patents
4. 1 out of 2,659 
 
University of Pennsylvania
 patents
5. 2 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1997-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Chimeric Polypeptides
Antibody Targeting
Modular Recognition Domains
Phage Particle Diagnostics
Chemically Programmed Vaccination
Zinc Finger Proteins
Multispecific Antibodies
Gene Expression Regulation
Monoclonal Antibodies
Heterodimeric Receptors
Catalytic Antibodies
Polypeptide Binding Sites
51 patents (USPTO):Explore Patents
1. 11466277 - Chimeric polypeptides having targeted binding specificity (2022-10-11),
2. 10829766 - Chimeric polypeptides having targeted binding specificity (2020-11-10),
3. 10030051 - Antibody targeting through a modular recognition domain (2018-07-24),
4. 9902962 - Chimeric polypeptides having targeted binding specificity (2018-02-27),
5. 9658224 - Phage particle diagnostic reagents (2017-05-23),
6. 9132188 - Chemically Programmed Vaccination (2015-09-15),
7. 8765920 - Tyrosine bioconjugation through aqueous Ene-like reactions (2014-07-01),
8. 8685687 - Chimeric zinc finger recombinases optimized for catalysis by directed evolution (2014-04-01),
9. 8574577 - VEGF antibodies comprising modular recognition domains (2013-11-05),
10. 8557243 - EFGR antibodies comprising modular recognition domains (2013-10-15),
11. 8557242 - ERBB2 antibodies comprising modular recognition domains (2013-10-15),
12. 8518927 - Chemically programmed vaccination (2013-08-27),
13. 8454960 - Multispecific antibody targeting and multivalency through modular recognition domains (2013-06-04),
14. 8252902 - Antibody targeting compounds (2012-08-28),
15. 7985841 - Heterodimeric receptor libraries using phagemids (2011-07-26),

Title: Inventor Carlos F Barbas, III

Introduction: Carlos F Barbas, III is a renowned inventor based in Solana Beach, California. He is known for his groundbreaking contributions to the field of innovation and patents.

Latest Patents: Carlos F Barbas, III holds several patents in various industries, showcasing his diverse range of expertise and creativity.

Career Highlights: With a successful career spanning several decades, Carlos F Barbas, III has established himself as a leading figure in the world of inventions. His innovative solutions have revolutionized the way we approach challenges in different sectors.

Collaborations: Throughout his career, Carlos F Barbas, III has collaborated with top companies, research institutions, and universities to bring his inventions to life. His partnerships have led to the development of cutting-edge technologies that have had a significant impact on society.

Conclusion: In conclusion, Carlos F Barbas, III's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor. His work continues to inspire future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…